FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Batlle

Research Profile

Concepts & Ideas

Hydrogen-Ion Concentration

Disorders

Living Beings

Rats

Chemicals & Drugs

Anatomy

Physiology

Glomerular Filtration Rate

Co-author Network

Publications

TOP 3
Minghao Ye; Karla Evora; Laura Garcia-Halpin; Francisco R Gonzalez-Pacheco; Marko Poglitsch; Mahmoud Salem; Manfred Schuster; Jan Wysocki; Daniel Batlle
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
Renisha Nadarajah; Jan Wysocki; Fengxia Xiao; Joseph Zimpelmann; Marc Dilauro; Alex Gutsol; Chris Kennedy; Rosangela Milagres; Daniel Batlle; Kevin D Burns
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice.
Daniel Batlle; María José Soler; Jan Wysocki; Keerthi Ranganath
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Batlle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Minghao Ye; Karla Evora; Laura Garcia-Halpin; Francisco R Gonzalez-Pacheco; Marko Poglitsch; Mahmoud Salem; Manfred Schuster; Jan Wysocki; Daniel Batlle
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
Hypertension 2012;60(3):730-40.
2012: Renisha Nadarajah; Jan Wysocki; Fengxia Xiao; Joseph Zimpelmann; Marc Dilauro; Alex Gutsol; Chris Kennedy; Rosangela Milagres; Daniel Batlle; Kevin D Burns
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice.
Kidney international 2012;82(3):292-303.
2012: Daniel Batlle; María José Soler; Jan Wysocki; Keerthi Ranganath
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy.
Kidney international 2012;81(6):520-8.
2012: María José Soler; Marta Riera; Daniel Batlle
New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy.
Experimental diabetes research 2012;2012():616313.
2010: Daniel Batlle; Maria Jose Soler; Minghao Ye
ACE2 and diabetes: ACE of ACEs?
Diabetes 2010;59(12):2994-6.
2010: Vaibhav Sahni; Robert Rosa; Daniel Batlle
Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKD.
Kidney international 2010;78(11):1065-7.
2010: Pottumarthi Prasad; Lu-Ping Li; Sarah Halter; Joann Cabray; Minghao Ye; Daniel Batlle
Evaluation of renal hypoxia in diabetic mice by BOLD MRI.
Investigative radiology 2010;45(12):819-22.
2010: Daniel Batlle; Jan Wysocki; Mirza S Khan
Vascular angiotensin-converting enzyme 2: lord of the ring?
Circulation research 2010;107(7):822-4.
2010: Kalea Anastasia; Daniel Batlle
Apelin and ACE2 in cardiovascular disease.
Current opinion in investigational drugs (London, England : 2000) 2010;11(3):273-82.
2010: Maria Aurora Posadas; Vincent Yang; Bing Ho; Muhammad Omer; Daniel Batlle
Acute renal failure and severe hypertension from a page kidney post-transplant biopsy.
TheScientificWorldJournal 2010;10():1539-42.
2010: Jan Wysocki; Minghao Ye; Eva Rodriguez; Francisco R González-Pacheco; Clara Barrios; Karla Evora; Manfred Schuster; Hans Loibner; K Bridget Brosnihan; Carlos M Ferrario; Josef M Penninger; Daniel Batlle
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
Hypertension 2010;55(1):90-8.
2009: María José Soler; Minghao Ye; Jan Wysocki; Josette William; Josep Lloveras; Daniel Batlle
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan.
American journal of physiology. Renal physiology 2009;296(2):F398-405.
2009: Xiaofang Wang; Peter C Harris; Stefan Somlo; Daniel Batlle; Vicente E Torres
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(2):526-34.
2009: Alexander Lauder; Arrigo Schieppati; Ferruccio Conte; Giuseppe Remuzzi; Daniel Batlle
Low mortality and key aspects of delivery of care for end-stage renal disease in Italy.
TheScientificWorldJournal 2009;9():349-59.
2008: María José Soler; Clara Barrios; Raymond Oliva; Daniel Batlle
Pharmacologic modulation of ACE2 expression.
Current hypertension reports 2008;10(5):410-4.
2008: María José Soler; Josep Lloveras; Daniel Batlle
[Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system].
Medicina clínica 2008;131(6):230-6.
2008: Andres Serrano; Daniel Batlle
Images in clinical medicine. Bilateral kidney calcifications.
The New England journal of medicine 2008;359(1):e1.
2008: Daniel Batlle; María José Soler; Jan Wysocki
New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.
Current opinion in nephrology and hypertension 2008;17(3):250-7.
2008: María José Soler; Jan Wysocki; Daniel Batlle
Angiotensin-converting enzyme 2 and the kidney.
Experimental physiology 2008;93(5):549-56.
2008: Jan Wysocki; Francisco R González-Pacheco; Daniel Batlle
Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease.
Current hypertension reports 2008;10(1):70-7.
2008: Vincent L Yang; Daniel Batlle
Acute renal failure from adulteration of milk with melamine.
TheScientificWorldJournal 2008;8():974-5.
2008: Jennifer Tuazon; David Casalino; Ehteshamuddin Syed; Daniel Batlle
Lithium-associated kidney microcysts.
TheScientificWorldJournal 2008;8():828-9.
2007: María José Soler; J Wysocki; M Ye; Josep Lloveras; Y Kanwar; Daniel Batlle
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.
Kidney international 2007;72(5):614-23.
2007: Sheldon Chen; Nishant Jalandhara; Daniel Batlle
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Nature clinical practice. Nephrology 2007;3(2):82-95.
2007: Arturo Briva; István Vadász; Emilia Lecuona; Lynn C Welch; Jiwang Chen; Laura A Dada; Humberto Trejo; Vidas Dumasius; Zaher S Azzam; Pavlos Makarios Myrianthefs; Daniel Batlle; Yosef Gruenbaum; Jacob I Sznajder
High CO2 levels impair alveolar epithelial function independently of pH.
PloS one 2007;2(11):e1238.
2007: J DeSantiago; Daniel Batlle; M Khilnani; S Dedhia; J Kulczyk; R Duque; J Ruiz; Cecilia Pena-Rasgado; Hector Rasgado-Flores
Ca2+ /H+ exchange via the plasma membrane Ca2+ ATPase in skeletal muscle.
Frontiers in bioscience : a journal and virtual library 2007;12():4641-60.
2007: Andres Serrano; Rajani K Chilakapati; Alexander J Ghanayem; Yemin Yuan; Jeffery Alberts; Cathy Stephen; Giuseppe Rombola; Daniel Batlle
Intestinal ileus as a possible cause of hypobicarbonatemia.
TheScientificWorldJournal 2007;7():75-9.
2007: Andres Serrano; Jie Huang; Cybele Ghossein; Laura Nishi; Anupama Gangavathi; Vijayachitra Madhan; Paramesh Ramadugu; Shubhada N Ahya; James Paparello; Neenoo Khosla; William Schlueter; Daniel Batlle
Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
Advances in chronic kidney disease 2007;14(1):105-12.
2006: Daniel Batlle; K M L S T Moorthi; William Schlueter; Neil Kurtzman
Distal renal tubular acidosis and the potassium enigma.
Seminars in nephrology 2006;26(6):471-8.
2006: Shubhada N Ahya; Maria José Soler; Josh Levitsky; Daniel Batlle
Acid-base and potassium disorders in liver disease.
Seminars in nephrology 2006;26(6):466-70.
2006: Minghao Ye; Jan Wysocki; Josette William; Maria José Soler; Ivan Cokic; Daniel Batlle
Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
Journal of the American Society of Nephrology : JASN 2006;17(11):3067-75.
2006: Patricia Valles; Michael S LaPointe; Jan Wysocki; Daniel Batlle
Kidney vacuolar H+ -ATPase: physiology and regulation.
Seminars in nephrology 2006;26(5):361-74.
2006: Jan Wysocki; Minghao Ye; Maria José Soler; Susan B Gurley; Hong D Xiao; Kenneth E Bernstein; Thomas M Coffman; Sheldon Chen; Daniel Batlle
ACE and ACE2 activity in diabetic mice.
Diabetes 2006;55(7):2132-9.
2006: Daniel W Coyne; Muralidhar Acharya; Ping Qiu; Hanna Abboud; Daniel Batlle; Steven Rosansky; Stephen Z Fadem; Barton Levine; Laura Williams; Dennis L Andress; Stuart M Sprague
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(2):263-76.
2006: Daniel Batlle
Carlos Margarit in memoriam, 1950-2005.
TheScientificWorldJournal 2006;6():318-52.
2006: Hanna Abboud; Daniel W Coyne; Olgierd Smolenski; Michael Anger; Norman Lunde; Ping Qiu; Richard L Hippensteel; Rajendra S Pradhan; Rameshraja Palaparthy; Anne Kavanaugh; Joel Melnick; Laura A Williams; Daniel Batlle
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
American journal of nephrology 2006;26(1):105-14.
2005: Rajiv Agarwal; Muralidhar Acharya; Jin Tian; Richard L Hippensteel; Joel Melnick; Ping Qiu; Laura Williams; Daniel Batlle
Antiproteinuric effect of oral paricalcitol in chronic kidney disease.
Kidney international 2005;68(6):2823-8.
2005: Patricia Valles; Jan Wysocki; Daniel Batlle
Angiotensin II and renal tubular ion transport.
TheScientificWorldJournal 2005;5():680-90.
2005: Josette William; Donn Hogan; Daniel Batlle
Predicting the development of diabetic nephropathy and its progression.
Advances in chronic kidney disease 2005;12(2):202-11.
2005: Daniel Batlle; Janet McGill; Mark Williams
Guest editorial: diabetic kidney disease.
Advances in chronic kidney disease 2005;12(2):126-7.
2005: Patricia Valles; Jan Wysocki; Mohammed Reza Salabat; Ivan Cokic; Minghao Ye; Michael S LaPointe; Daniel Batlle
Angiotensin II increases H+-ATPase B1 subunit expression in medullary collecting ducts.
Hypertension 2005;45(4):818-23.
2004: Naveen Singri; Duncan B Johnstone; James Paparello; Neenoo Khosla; Shubhada N Ahya; Cybele Ghossein; William Schlueter; Robert Rosa; Daniel Batlle; Murray L Levin
Effect of predialysis eating on measurement of urea reduction ratio and Kt/V.
Advances in chronic kidney disease 2004;11(4):398-403.
2004: K M L S T Moorthi; Donn Hogan; Empar Lurbe; Josep Redon; Daniel Batlle
Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease?
Current hypertension reports 2004;6(5):393-9.
2004: Minghao Ye; Jan Wysocki; Parveen Naaz; Mohammad Reza Salabat; Michael S LaPointe; Daniel Batlle
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?
Hypertension 2004;43(5):1120-5.
2003: Emilia Lecuona; Karen M Ridge; Liuska Pesce; Daniel Batlle; Jacob I Sznajder
The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells.
Molecular biology of the cell 2003;14(9):3888-97.
2003: Rajiv Agarwal; Allen R Nissenson; Daniel Batlle; Daniel W Coyne; J Richard Trout; David G Warnock
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
The American journal of medicine 2003;115(4):291-7.
2003: Daniel Batlle
Clinical and cellular markers of diabetic nephropathy.
Kidney international 2003;63(6):2319-30.
2003: Lixia Zeng; Yashpal S Kanwar; Nail Amro; Carrie Phillips; Mark Molitch; Daniel Batlle; Farhad R Danesh
Epigenetic and genetic analysis of p16 in dermal fibroblasts from type 1 diabetic patients with nephropathy.
Kidney international 2003;63(6):2094-102.
2003: Stuart M Sprague; Francisco Llach; Michael Amdahl; Carol Taccetta; Daniel Batlle
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
Kidney international 2003;63(4):1483-90.
2003: Daniel W Coyne; N FRANKLIN ADKINSON; Allen R Nissenson; Steven Fishbane; Rajiv Agarwal; Joseph W Eschbach; Beckie Michael; Vaughn W Folkert; Daniel Batlle; J Richard Trout; Naomi V Dahl; Pamela Myirski; Jur Strobos; David G Warnock
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Kidney international 2003;63(1):217-24.
2002: Donn Hogan; Empar Lurbe; Mohammad R Salabat; Josep Redon; Daniel Batlle
Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.
Current diabetes reports 2002;2(6):539-44.
2002: Cybele Ghossein; Andres Serrano; Meena Rammohan; Daniel Batlle
The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience.
Seminars in nephrology 2002;22(6):526-32.
2002: James Paparello; Abhijit V Kshirsagar; Daniel Batlle
Comorbidity and cardiovascular risk factors in patients with chronic kidney disease.
Seminars in nephrology 2002;22(6):494-506.
2002: Empar Lurbe; Josep Redon; Ajit Kesani; José M Pascual; Jose Tacons; Vicente Alvarez; Daniel Batlle
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.
The New England journal of medicine 2002;347(11):797-805.
2002: Michael S LaPointe; Chhinder Sodhi; Atul Sahai; Daniel Batlle
Na+/H+ exchange activity and NHE-3 expression in renal tubules from the spontaneously hypertensive rat.
Kidney international 2002;62(1):157-65.
2001: Stuart M Sprague; Edgar A. Lerma; D McCormmick; M Abraham; Daniel Batlle
Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(5 Suppl 5):S51-6.
2001: Michael S LaPointe; Daniel Batlle
Cultured skin fibroblasts as an in vitro model to assess phenotypic features in subjects with diabetic nephropathy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(3):646-8.
2001: Chhinder Sodhi; S A Phadke; Daniel Batlle; Atul Sahai
Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose.
Diabetes 2001;50(6):1482-90.
2001: Chhinder Sodhi; S A Phadke; Daniel Batlle; Atul Sahai
Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin.
American journal of physiology. Renal physiology 2001;280(4):F667-74.
2001: D Stakisaitis; Michael S LaPointe; Daniel Batlle
Mechanisms of chloride transport in thymic lymphocytes.
American journal of physiology. Renal physiology 2001;280(2):F314-24.
2001: Daniel Batlle; H Ghanekar; S Jain; A Mitra
Hereditary distal renal tubular acidosis: new understandings.
Annual review of medicine 2001;52():471-84.
2000: C Wang; R Francis; S Harirchian; Daniel Batlle; Bobbie A Mayhew; M Bassett; William E Rainey; Richard G Pestell
The application of high density microarray for analysis of mitogenic signaling and cell-cycle in the adrenal.
Endocrine research 2000;26(4):807-23.
2000: Chhinder Sodhi; Daniel Batlle; Atul Sahai
Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK.
Kidney international 2000;58(2):691-700.
1999: Farhad R Danesh; M Ye; S Salmi; Michael S LaPointe; Daniel Batlle
Temporal profile of serum-induced S-phase entry and retinoblastoma protein phosphorylation in human skin fibroblasts.
Kidney international 1999;56(4):1282-5.
1999: D Sisson; Daniel Batlle
Aquaporin-2 as a biomarker of distal renal tubular function using lithium as an experimental model.
Renal failure 1999;21(3-4):331-6.
1999: T Keilani; Farhad R Danesh; William Schlueter; A Molteni; Daniel Batlle
A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(3):450-7.
1998: Farhad R Danesh; Daniel Batlle
H+-ATPase in hyperkalemic distal renal tubular acidosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(6):1091-5; discussion 1095-7.
1998: Melvin M Schwartz; Edmund J Lewis; T Leonard-Martin; J B Lewis; Daniel Batlle
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(10):2547-52.
1998: I W Gallen; Robert Rosa; D Y Esparaz; J B Young; Gray L Robertson; Daniel Batlle; F H Epstein; L Landsberg
On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(1):19-27.
1997: Michael S LaPointe; Minghao Ye; R Bacallao; Daniel Batlle
NHE-1 protein in vascular smooth muscle and lymphocytes from the spontaneously hypertensive rat.
Hypertension 1997;30(4):880-5.
1997: Jun Wada; A Kumar; Kosuke Ota; Elisabeth I Wallner; Daniel Batlle; Yashpal S Kanwar
Representational difference analysis of cDNA of genes expressed in embryonic kidney.
Kidney international 1997;51(5):1629-38.
1996: A Lurbe; Paola Fioretto; Michael Mauer; M S LaPointe; Daniel Batlle
Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter.
Kidney international 1996;50(5):1684-93.
1996: G Watanabe; R J Lee; Chris Albanese; William E Rainey; Daniel Batlle; R G Pestell
Angiotensin II activation of cyclin D1-dependent kinase activity.
The Journal of biological chemistry 1996;271(37):22570-7.
1996: G Flores; M Ye; M LaPointe; Daniel Batlle
Ionic effects of angiotensin II and their role in the activation of the Na+/H+ antiporter.
Kidney international. Supplement 1996;55():S122-5.
1996: Daniel Batlle; G Flores
Underlying defects in distal renal tubular acidosis: new understandings.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;27(6):896-915.
1996: M Ye; G Flores; Daniel Batlle
Angiotensin II and angiotensin-(1-7) effects on free cytosolic sodium, intracellular pH, and the Na(+)-H+ antiporter in vascular smooth muscle.
Hypertension 1996;27(1):72-8.
1995: T Keilani; W Schlueter; Daniel Batlle
Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium.
Journal of clinical pharmacology 1995;35(1):87-97.
1995: M S LaPointe; M Ye; O W Moe; Robert J Alpern; Daniel Batlle
Na+/H+ antiporter (NHE-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat.
Kidney international 1995;47(1):78-87.
1994: Daniel Batlle; J Redon; Cory Gutterman; M LaPointe; A Saleh; A Sharma; G Rombola; M Ye; W Alsheikha; L Gomez
Acid-base status and intracellular pH regulation in lymphocytes from rats with genetic hypertension.
Journal of the American Society of Nephrology : JASN 1994;5(5 Suppl 1):S12-22.
1994: J Redon; Daniel Batlle
Regulation of intracellular pH in the spontaneously hypertensive rat. Role of bicarbonate-dependent transporters.
Hypertension 1994;23(4):503-12.
1994: M S LaPointe; Daniel Batlle
Na+/H+ exchange and vascular smooth muscle proliferation.
The American journal of the medical sciences 1994;307 Suppl 1():S9-16.
1994: W Schlueter; T Keilani; Daniel Batlle
Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
The American journal of the medical sciences 1994;307 Suppl 1():S81-6.
1993: W Schlueter; T Keilani; Daniel Batlle
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
The American journal of cardiology 1993;72(20):37H-44H.
1993: Daniel Batlle; Arya Sharma; M W Alsheikha; M Sobrero; A Saleh; Cory Gutterman
Renal acid excretion and intracellular pH in salt-sensitive genetic hypertension.
The Journal of clinical investigation 1993;91(5):2178-84.
1993: Daniel Batlle; R Peces; M S LaPointe; M Ye; John T Daugirdas
Cytosolic free calcium regulation in response to acute changes in intracellular pH in vascular smooth muscle.
The American journal of physiology 1993;264(4 Pt 1):C932-43.
1993: T Keilani; W A Schlueter; M L Levin; Daniel Batlle
Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
Annals of internal medicine 1993;118(4):246-54.
1993: A Lurbe; Josep Redón; José M Pascual; Jose Tacons; Vicente Alvarez; Daniel Batlle
Altered blood pressure during sleep in normotensive subjects with type I diabetes.
Hypertension 1993;21(2):227-35.
1992: W Schlueter; T Keilani; M Hizon; B Kaplan; Daniel Batlle
On the mechanism of impaired distal acidification in hyperkalemic renal tubular acidosis: evaluation with amiloride and bumetanide.
Journal of the American Society of Nephrology : JASN 1992;3(4):953-64.
1992: John T Daugirdas; Daniel Batlle
Interactions of pHi and Ca2+i in vascular smooth muscle tissue.
The Journal of laboratory and clinical medicine 1992;119(6):667-75.
1992: N A Nora; R Hedger; Daniel Batlle
Severe acute peripartum hypernatremia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1992;19(4):385-8.
1992: C W Nutting; S Islam; M H Ye; Daniel Batlle; John T Daugirdas
The vasorelaxant effects of acetate: role of adenosine, glycolysis, lyotropism, and pHi and Cai2+.
Kidney international 1992;41(1):166-74.
1991: Daniel Batlle; M Godinich; M S LaPointe; E Munoz; FA Carone; N Mehring
Extracellular Na+ dependency of free cytosolic Ca2+ regulation in aortic vascular smooth muscle cells.
The American journal of physiology 1991;261(5 Pt 1):C845-56.
1991: M M Salem; Robert Rosa; Daniel Batlle
Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;18(4):421-40.
1991: A M Saleh; G Rombola; Daniel Batlle
Intracellular H+ buffering power and its dependency on intracellular pH.
Kidney international 1991;39(2):282-8.
1991: Daniel Batlle; Robert J Alpern
Regulation of intracellular pH. Introduction.
Seminars in nephrology 1991;11(1):1-2.
1991: A M Saleh; Daniel Batlle
Basic mechanisms of intracellular pH homeostasis in lymphocytes.
Seminars in nephrology 1991;11(1):3-15.
1991: B A Hansen; Daniel Batlle; Martha E O'Donnell
Sodium-calcium exchange in bovine aortic endothelial cells.
Annals of the New York Academy of Sciences 1991;639():566-9.
1991: M Godinich; M S LaPointe; Daniel Batlle
Free cytosolic calcium regulation via Na(+)-Ca2+ exchange in cultured vascular smooth muscle cells.
Annals of the New York Academy of Sciences 1991;639():561-5.
1990: A M Saleh; Daniel Batlle
Kinetic properties of the Na+/H+ antiporter of lymphocytes from the spontaneously hypertensive rat: role of intracellular pH.
The Journal of clinical investigation 1990;85(6):1734-9.
1990: Daniel Batlle; G Janss; M LaPointe; J Llibre; A Saleh
Cytosolic calcium in T lymphocytes from the spontaneously hypertensive rat.
American journal of hypertension 1990;3(5 Pt 1):343-8.
1990: M J Godinich; Daniel Batlle
Renal tubular effects of lithium.
Kidney international. Supplement 1990;28():S52-7.
1990: Daniel Batlle; Cory Gutterman; T Keilani; R Peces; M LaPointe
Effect of cyclosporin A on renal function and kidney growth in the uninephrectomized rat.
Kidney international 1990;37(1):21-8.
1990: Daniel Batlle; A Saleh; G Rombola
Reduced intracellular pH in lymphocytes from the spontaneously hypertensive rat.
Hypertension 1990;15(1):97-103.
1989: W A Schlueter; Daniel Batlle
Renal effects of antihypertensive drugs.
Drugs 1989;37(6):900-25.
1989: Daniel Batlle; Y L Chan
Effect of L-arginine on renal tubular bicarbonate reabsorption by the rat kidney.
Mineral and electrolyte metabolism 1989;15(4):187-94.
1988: E Cohen; K Liu; Daniel Batlle
Patterns of metabolic acidosis in patients with chronic renal failure: impact of hemodialysis.
The International journal of artificial organs 1988;11(6):440-8.
1988: J Llibre; M S LaPointe; Daniel Batlle
Free cytosolic calcium in renal proximal tubules from the spontaneously hypertensive rat.
Hypertension 1988;12(4):399-404.
1988: Daniel Batlle; W Schlueter; Cory Gutterman; N A Kurtzman
Assessment of collecting tubule hydrogen ion secretion in acute respiratory alkalosis using the urinary pCO2.
Pflügers Archiv : European journal of physiology 1988;411(6):692-4.
1988: Daniel Batlle; M Hizon; E Cohen; Cory Gutterman; R Gupta
The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis.
The New England journal of medicine 1988;318(10):594-9.
1988: S Mujais; Daniel Batlle
Functional correlates of tubulo-interstitial damage.
Seminars in nephrology 1988;8(1):94-9.
1988: W Schlueter; Daniel Batlle
Chronic obstructive nephropathy.
Seminars in nephrology 1988;8(1):17-28.
1988: Daniel Batlle; S Sabatini; N A Kurtzman
On the mechanism of toluene-induced renal tubular acidosis.
Nephron 1988;49(3):210-8.
1987: R Boton; Moises Gaviria; Daniel Batlle
Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1987;10(5):329-45.
1987: Daniel Batlle; A von Riotte; W Schlueter
Urinary sodium in the evaluation of hyperchloremic metabolic acidosis.
The New England journal of medicine 1987;316(3):140-4.
1986: Daniel Batlle
Segmental characterization of defects in collecting tubule acidification.
Kidney international 1986;30(4):546-54.
1986: Daniel Batlle
Sodium-dependent urinary acidification in patients with aldosterone deficiency and in adrenalectomized rats: effect of furosemide.
Metabolism: clinical and experimental 1986;35(9):852-60.
1986: Daniel Batlle; J Libre
Renal and hemodynamic effects of non-diuretic antihypertensive therapy.
Seminars in nephrology 1986;6(3):224-40.
1986: Daniel Batlle; W C Yang; A Von Riotte; S K Mujais
Dissociation between the hypotensive effect of thiazides and plasma divalent cations.
Advances in experimental medicine and biology 1986;208():433-41.
1986: Daniel Batlle; A von Riotte; G Lang
Delayed hypotensive response to dialysis in hypertensive patients with end-stage renal disease.
American journal of nephrology 1986;6(1):14-20.
1986: Daniel Batlle; Cory Gutterman; J Tarka; R Prasad
Effect of short-term cyclosporine A administration on urinary acidification.
Clinical nephrology 1986;25 Suppl 1():S62-9.
1986: W C Yang; T P Huang; L T Ho; H M Chung; Y L Chan; Daniel Batlle
Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
Mineral and electrolyte metabolism 1986;12(3):186-93.
1985: Daniel Batlle; M Downer; Cory Gutterman; N A Kurtzman
Relationship of urinary and blood carbon dioxide tension during hypercapnia in the rat. Its significance in the evaluation of collecting duct hydrogen ion secretion.
The Journal of clinical investigation 1985;75(5):1517-30.
1985: Daniel Batlle; A B von Riotte; Moises Gaviria; M Grupp
Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy.
The New England journal of medicine 1985;312(7):408-14.
1985: Daniel Batlle; W Schlueter; R Foley; N A Kurtzman
Urinary pCO2 as an index of collecting duct hydrogen ion secretion during chronic hypercapnia.
Mineral and electrolyte metabolism 1985;11(4):230-9.
1984: Daniel Batlle; N A Kurtzman
Clinical disorders of aldosterone metabolism.
Disease-a-month : DM 1984;30(8):1-55.
1984: M Cruz-Soto; J P Frommer; K Itsarayoungyuen; Daniel Batlle; Jose A L Arruda; N A Kurtzman
Carbonic anhydrase independent bicarbonate reabsorption in rats with chronic papillary necrosis.
Mineral and electrolyte metabolism 1984;10(5):319-25.
1983: Daniel Batlle; K Itsarayoungyuen; M Downer; R Foley; Jose A L Arruda; N A Kurtzman
Suppression of distal urinary acidification after recovery from chronic hypocapnia.
The American journal of physiology 1983;245(4):F433-42.
1983: Daniel Batlle; N A Kurtzman
Syndromes of aldosterone deficiency and excess.
The Medical clinics of North America 1983;67(4):879-902.
1983: Daniel Batlle
Renal tubular acidosis.
The Medical clinics of North America 1983;67(4):859-78.
1982: M Cruz-Soto; Daniel Batlle; S Sabatini; Jose A L Arruda; N A Kurtzman
Distal acidification in the rabbit: role of diet and blood pH.
The American journal of physiology 1982;243(4):F364-71.
1982: Daniel Batlle; K Itsarayoungyuen; S Hays; Jose A L Arruda; N A Kurtzman
Parathyroid hormone is not anticalciuric during chronic metabolic acidosis.
Kidney international 1982;22(3):264-71.
1982: Jose A L Arruda; V Alla; H Rubinstein; M Cruz-Soto; S Sabatini; Daniel Batlle; N A Kurtzman
Metabolic and hormonal factors influencing extrarenal buffering of an acute acid load.
Mineral and electrolyte metabolism 1982;8(1):36-43.
1982: Daniel Batlle; N A Kurtzman
Distal renal tubular acidosis: pathogenesis and classification.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1982;1(6):328-44.
1982: Daniel Batlle; M Grupp; Moises Gaviria; N A Kurtzman
Distal renal tubular acidosis with intact capacity to lower urinary pH.
The American journal of medicine 1982;72(5):751-8.
1982: Daniel Batlle; Moises Gaviria; M Grupp; Jose A L Arruda; J Wynn; N A Kurtzman
Distal nephron function in patients receiving chronic lithium therapy.
Kidney international 1982;21(3):477-85.
1982: Daniel Batlle; K Itsarayoungyuen; Jose A L Arruda; N A Kurtzman
Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies.
The American journal of medicine 1982;72(2):188-92.
1982: Daniel Batlle; S Hays; R Foley; Y Chan; Jose A L Arruda; N A Kurtzman
Proximal renal tubular acidosis and hypophosphatemia induced by arginine.
Advances in experimental medicine and biology 1982;151():239-49.
1981: Daniel Batlle; John T Sehy; M K Roseman; Jose A L Arruda; N A Kurtzman
Clinical and pathophysiologic spectrum of acquired distal renal tubular acidosis.
Kidney international 1981;20(3):389-96.
1981: Daniel Batlle
IgA glomerulonephritis, asymptomatic hematuria, and systemic disease.
Archives of internal medicine 1981;141(10):1264-5.
1981: Daniel Batlle; MF Mozes; J Manaligod; Jose A L Arruda; N A Kurtzman
The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation.
The American journal of medicine 1981;70(4):786-96.
1981: Daniel Batlle; Jose A L Arruda; N A Kurtzman
Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy.
The New England journal of medicine 1981;304(7):373-80.
1981: Jose A L Arruda; Daniel Batlle; John T Sehy; M K Roseman; R L Baronowski; N A Kurtzman
Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone.
American journal of nephrology 1981;1(3-4):160-7.
1980: Jose A L Arruda; V Alla; H Rubinstein; M Cruz-Soto; S Sabatini; Daniel Batlle; N A Kurtzman
Parathyroid hormone and extrarenal acid buffering.
The American journal of physiology 1980;239(6):F533-8.
1980: Daniel Batlle; S Hays; Jose A L Arruda; N A Kurtzman
Parathyroid hormone dependent hypercalciuria in chronic metabolic acidosis.
Advances in experimental medicine and biology 1980;128():515-22.